Lewis Cantley is a Professor of Cell Biology at Harvard University and Dana-Farber Cancer Institute, where he also serves as a faculty member. He previously directed the Meyer Cancer Center at Weill Cornell from 2003 to 2012. His research focuses on cancer metabolism, PI3K-AKT signaling, phosphoinositide biology, and tyrosine kinase substrate specificity. Recent work includes pan-cancer proteogenomics of tumor immunity, lineage-specific oncogenic driver intolerance, and mitochondrial reductive stress in glioblastoma. He has received multiple major grants for studies on phosphoinositides in cancer metabolism and collaborates extensively with institutions across the US, Europe, Asia, and Australia.
See moreHonors

Experiences

Education
